EphA2 siRNA in Treating Patients With Advanced or Recurrent Solid Tumors
Clinical trial NCT01591356 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT01591356
- Sponsor
- M.D. Anderson Cancer Center
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-07-01
- Primary completion
- 2027-04-30
- Enrollment
- 49
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.